Scientific Publications
Service Providers
Flexible ways to complete your studies—your own lab or outsource
Affymetrix service providers give you an additional option for completing your study. In an effort to speed your discovery, we have built a comprehensive network of service providers that have demonstrated the strongest level of commitment to customer satisfaction. When you partner with an authorized Affymetrix service provider, you can be assured that you will receive the highest-quality data.
In addition, we provide Affymetrix-owned and -operated CLIA-certified diagnostic services and high-throughput genotyping services for fast and affordable data results.
Work directly with our broad network of service providers
Being on the forefront of technology is important to us at Affymetrix, and we are dedicated to helping you advance your research. The following partners offer outstanding services using Affymetrix® GeneChip® technology:
China
CapitalBio
Headquartered in Beijing, China, CapitalBio is a leading life science Company that develops and commercializes total health-care solutions including a broad range of innovative biochip-related products for genomic and proteomic research, bio-safety testing, clinical applications and to address wider human health needs.
Shanghai Biochip
Shanghai Biochip is the first Affymetrix-certified technical service provider in China.
India
Vimta Labs Limited
Vimta Labs is India's leading contract research and testing organization. Established in 1984 VIMTA has an envious track record of serving several market leaders across the globe.
Japan
Bio Matrix Research
Bio Matrix Research, a bio-venture company launched by the Tokyo University of Science, conducts innovative research and is engaged in the development and commercialization of unique products. Scientific advances are the outgrowth of technological development. BMR develops technologies that drive the dynamic development in the fields of molecular biology, medicine, and pharmacology
GeneticLab Co., Ltd
GeneticLab Co., Ltd. specializes in the biotechnologies relevant to genome-wide expression analysis and drug discovery based on nucleic acid chemistry.
KURABO
Textile manufacturer Kurabo Industries weaves its way into more than just apparel. The company produces yarn and knitted and woven fabrics primarily from cotton, wool, and synthetic materials. Kurabo's fabrics are used in clothing as well in filters for the chemical and biomedical industries. Kurabo was founded in 1888.
Mitsubishi Chemical Safety Institute Ltd.
Mitsubishi Chemical Safety Institute Ltd. is famous for its outstanding analytical ability in the medical and pharmaceutical fields.
Pharma Frontier & Co.
Sekisui Chemical Co., Ltd.
Sekisui Chemical Co., Ltd. is engaged in manufacture of plastics. The company markets its products to the industries including IT materials, medical, housing and water environment solutions. It also offers high performance plastic products, including medical-related products, fine chemicals, and specialty chemicals, such as resins.
TaKaRa Bio Inc.
As an R&D-oriented organization, Takara Bio is dedicated to the development of biotechnology-related products and technologies. The Genetic engineering research business started in 1979, when we began sales of the first domestically produced restriction enzymes. For over a quarter of century since then, Takara Bio has vigorously explored the potential of genes and DNA engineering.
Singapore
Origen
Work directly with our broad network of service providers
Being on the forefront of technology is important to us at Affymetrix, and we are dedicated to helping you advance your research. The following partners offer outstanding services using Affymetrix® GeneChip® technology:
Belgium
DNAVision SA
DNAVision can provide you with GLP certified*, ISO17025 accredited, and CLIA certified services, such as:
- A wide range and the latest applications (DNA/RNA): Exon ST, SNP 6.0, Custom SNP genotyping, Resequencing,...
- In a high quality environment: First European lab to be GLP certified for Pharmacogenomic and toxicogenomic and ISO17025 accredited for expression profiling and genotyping. CLIA registered and CAP compliant, partner of the MAQC phase 2 project.
- With a wide range of sample type: PAXgene™, RNAlater®, FFPE, FACS sorted cells,...
- With a huge expertise in biostatistics (expression profiling, DNA genotyping (SNPs and CNV)), data mining and management of large data sets for efficient pathways and ontology screening.
Denmark
AROS Applied Biotechnology
AROS Applied Biotechnology is the leading provider of Total Genomic Solutions in Europe. The company covers all steps from extraction, sample banking, and analysis to advanced bioinformatics. GLP Certified*
France
CIT - Centre Int'l of Tox
CIT delivers a complete integrated toxicogenomics solution from in vivo studies to data mining, including:
- Assistance in customized toxicogenomics study design
- In vivo phase in rats, dogs, pigs or primates
- Optimized tissue sampling and RNA extraction procedures to ensure top level quality RNAs from more than 50 tissues
- Whole transcriptome profiling on Affymetrix Genechip® arrays
- Complete data analysis
- Identification of toxicity mechanisms and predictive toxicity by data comparison with toxicity signature databases.
- Each step can be standalone or integrated following an in vivo phase conducted at CIT.
CIT is a contract research organisation (CRO) specialized in safety and health research. Within the three last decades, CIT has conducted projects for human and veterinary pharmaceutical, biotechnology, chemical, agrochemical and consumer product companies and have contributed to many registrations around the world.
Exonhit Therapeutics
ExonHit Therapeutics is a world leader in the analysis of alternative RNA splicing, a biological process which when deregulated plays a key role in the onset of various diseases. Developed on the Affymetrix platform, ExonHit Therapeutic's SpliceArray™ is a platform technology that can be applied to drug target and gene signature biomarker discovery and development by detecting expression differences between multiple transcripts or isoforms that are generated from a single locus as a result of alternative splicing. ExonHit offers a comprehensive genomic service for clients to analyze your RNA samples on microarrays manufactured by Affymetrix to detect and differentiate splice variants based on our SpliceArray™ patented design approach.
IPSOGEN
Ipsogen is a cancer profiler that develops and markets molecular diagnostic tests designed to map diseases in order to guide patient and oncologists decision along their complex therapeutic path.
Germany
ATLAS Biolabs
ATLAS Biolabs GmbH runs all available gene expression as well as genome-wide SNP genotyping assays and disposes of high processing capacities (6 scanners, 17 fluidics stations). Since 2001 our personnel has hybridized tens of thousands of Affymetrix GeneChips™ in many national and international projects. Supervised by our medical director, a professor of human genetics, genome-wide human SNP arrays are used for diagnostics in mentally retarded children. ATLAS Biolabs is located in "Medical Center 147" in the center of Berlin.
Epidauros Biotechnologie AG
Epidauros Biotechnologie AG, a Clinical Data® company, has established itself as a worldwide leading Pharmacogenetic Research Organization (PRO) providing innovative, integrated and value-added solutions in pharmacogenetics to an international customer base consisting of pharmaceutical companies, CROs and other companies acting in the field of health care. Since its foundation in 1997, Epidauros has brought together a network of competent partners to do pharmacogenetic-related research and has established its own intellectual property base in the field of drug transporters, e.g. MDR1 and cytochrome P450 enzymes. The company is located in Bernried near Munich.
GLP compliant*
DMET certified
ImaGenes
Stringent quality controls and standardized processing procedures are central features of Affymetrix service at imaGenes, which is documented by its ISO 9001:2000 certificate. Customers will be offered complete solutions ranging from initial project design to final multi-sample data analysis, e.g. hierarchical clustering or time-series analysis. In addition, imaGenes provides a unique way to get access to one of the world's largest clone and proteome resources directly from Affymetrix screening results - just by a click from the final results.
Switzerland
Biolytix AG
BIOLYTIX - SPECIALTY GENOMIC SERVICES WITH SWISS QUALITY
Located in the close proximity to the European life sciences powerhouse, Basel, Biolytix is offering premium quality genomic analysis services for the industry and academia.
The comprehensive, customer oriented portfolio includes extraction of genomic material (RNA, DNA) from various biological tissue types (including blood), assay development, validation (e.g. using qPCR) and a broad variety of genomic analysis services (using the Affymetrix GenChip system) compliant to industry standards and quality requirements. Specialities include e.g. gene expression analysis from plants and genotyping of animals, both with relevance in the agro business.
The well established quality (ISO/IEC 17025) and laboratory information management systems are providing the basis for a professional collaboration with the Pharma and biotech industry as well as academic institutions, hospitals and reference laboratories.
United Kingdom
Almac Diagnostics
Almac Diagnostics is a global leader in the provision of translational genomic-based solutions for Pharma, biotech and academic customers. They specialise in working with fresh and formallin fixed paraffin embedded (FFPE) tissue for generation of predictive and prognostic tests, drug development, target identification and companion diagnostics. Almac Diagnostics also offer their own range of disease specific microarrays, "DSA™ research tools". Based on the Affymetrix GeneChip® platform, these are the first high-density transcriptome based microarrays that focus on the transcriptome of a particular disease. ISO17025 accredited*
*These Affymetrix service providers state that they have met the FDA requirements associated with 21 CFR Part 58 and are in compliance with Good Laboratory Practices (GLP). Please note: Affymetrix has not performed independent verification of these statements and makes no representation or warranty regarding the validity of any such statement.
Work directly with our broad network of service providers
Being on the forefront of technology is important to us at Affymetrix, and we are dedicated to helping you advance your research. The following partners offer outstanding services using Affymetrix® GeneChip® technology:
Almac Diagnostics
Almac Diagnostics is a global leader in the provision of translational genomic-based solutions for Pharma, biotech and academic customers. They specialise in working with fresh and formallin fixed paraffin embedded (FFPE) tissue for generation of predictive and prognostic tests, drug development, target identification and companion diagnostics. Almac Diagnostics also offer their own range of disease specific microarrays, "DSA™ research tools". Based on the Affymetrix GeneChip® platform, these are the first high-density transcriptome based microarrays that focus on the transcriptome of a particular disease. ISO17025 accredited*
Asuragen™ Discovery & Clinical Research Services
Unique in the industry, Asuragen Services provides RNA/DNA sample prep and sample analysis services to meet the needs for the basic research, clinical research, and clinical development communities. Asuragen is a fully licensed service provider for Affymetrix®. No other service provider has the industry-leading platforms combined with so many cumulative years of experience in RNA. We offer a wide range of services for quantification and data analysis of DNA, RNA and microRNA with sample prep services for FFPE, fresh tissues, blood, other biofluids, and cells. GLP compliant*
Cogenics
Cogenics, Inc., a Clinical Data company, has consolidated the operations of Genaissance Pharmaceuticals, Inc., Lark Technologies, Inc., Icoria, Inc., and Genome Express SA to form a unique genomics services company that offers a comprehensive range of molecular biology and pharmacogenomics services to pharmaceutical, biotech, academic, and government clients. Cogenics has a proven record of scientific innovation and excellence in providing solutions-based services in support of research and development in genomics medicine and healthcare.
CLIA and GLP compliant*
DMET certified
Exonhit Therapeutics
ExonHit Therapeutics is a world leader in the analysis of alternative RNA splicing, a biological process which when deregulated plays a key role in the onset of various diseases. Developed on the Affymetrix platform, ExonHit Therapeutic's SpliceArray™ is a platform technology that can be applied to drug target and gene signature biomarker discovery and development by detecting expression differences between multiple transcripts or isoforms that are generated from a single locus as a result of alternative splicing. ExonHit offers a comprehensive genomic service for clients to analyze your RNA samples on microarrays manufactured by Affymetrix to detect and differentiate splice variants based on our SpliceArray™ patented design approach.
Expression Analysis
Expression Analysis is the industry leader in providing microarray-based genomic services for clinical trials using Affymetrix GeneChip® Microarrays.
GLP compliant*
DMET certified
GeneLogic
GeneLogic aims to be the drug development partner of choice for the pharmaceutical and biotechnology industries. Companies worldwide trust GeneLogic's proven portfolio of Genomics Services to help accelerate their drug development process. GLP compliant*
Genome Explorations
Genome Explorations provides Genotyping, Gene Expression and microRNA profiling services for Pharmaceutical, Biotech and Academic institutes worldwide. Genome Explorations utilizes the Affymetrix GeneChip® platform in their state of the art GLP laboratories.
GLP compliant*
GenPathway
Genpathway is your total solution for ChIP-on-Chip and Methylated DNA IP-on-Chip Assays. These assays, FactorPath™, TranscriptionPath™, and Methylated DNA, represent a powerful combination of Genpathway's high-quality chromatin immunoprecipitation (ChIP) and DNA IP assays with Affymetrix' whole-genome tiling arrays. Genpathway's technologies provide an immediate solution for analyzing gene regulation by transcription factors and co-regulators, gene transcription, and epigenetic changes. Provided as a comprehensive service, each assay includes the complete ChIP/DNA IP procedure from chromatin/DNA preparation to antibody qualification, chromatin/DNA validation, multiple QC steps, use of optimized ChIP/DNA IP protocols, and complete analysis of results in an easy-to-view format.
Precision Biomarker Resources
Precision Biomarker Resources provides automated, high-throughput microarray services using the latest Affymetrix GeneChip Microarray platform to expedite the biologic investigations of pharmaceutical, biotechnology and academic researchers.
Response Genetics, Inc.
Response Genetics is a world leading company in the analysis of formalin fixed paraffin embedded tissue (FFPE) with laboratories in both North America and Europe. Response Genetics is an Affymetrix authorized service provider for FFPE tissue with the capability of analyzing microdissected tissue for gene expression by microarray (U133 plus 2.0). The company's laboratories are GLP-compliant and CLIA certified (U.S.) for handling patient samples.
SeqWright
SeqWright Incorporated is a world-class genomic services support organization based in Houston, TX with more than a decade of experience specializing in providing access to state of the art Molecular Biology and Genomic services in a highly regulated GLP/CLIA environment (CLIA and GLP compliant*).
*These Affymetrix service providers state that they have met the FDA requirements associated with 21 CFR Part 58 and are in compliance with Good Laboratory Practices (GLP). Please note: Affymetrix has not performed independent verification of these statements and makes no representation or warranty regarding the validity of any such statement.